ADVFN - Advanced Financial Network.
HOME» NYSE » V » VRX Stock Price » VRX Stock News

Valeant Pharma Share News

 Valeant Pharmaceuticals International Stock Price
VRX Stock Price
 Valeant Pharmaceuticals International Stock Chart
VRX Stock Chart
 Valeant Pharmaceuticals International Stock News
VRX Stock News
 Valeant Pharmaceuticals International Company Information
VRX Company Information
 Valeant Pharmaceuticals International Stock Trades
VRX Stock Trades

Sanofi Sells Dermik Unit To Valeant For $425 Million

PARIS -(Dow Jones)- French pharmaceutical giant Sanofi SA (SAN.FR) said Monday it sold Dermik, its dermatology unit, to Canada-based Valeant Pharmaceuticals International Inc. (VRX) for $425 million in cash. The transaction involves Dermik assets, comprising an aesthetic and therapeutic dermatology business in the U.S. and Canada and an aesthetic dermatology business in other parts of the world, which had sales of $206 million in 2010, Sanofi said. Dermik has a significant presence in the medical dermatology market in the U.S. and Canada, with a strong field force and well-known brands, which include BenzaClin, Carac and Sculptra. Sanofi decided to sell Dermik to focus on its "growth platforms" and "innovation." The French company recently bought U.S. biotech firm Genzyme for $20 billion and a string of smaller firms prior to the Genzyme takeover. The transaction will still have to be cleared by certain antitrust authorities and meet other customary conditions. -By Inti Landauro, Dow Jones Newswires; +33 1 4017 1740;

Stock News for Valeant Pharma (VRX)
11/25/201511:30:00Prescription Skin Drugs Explode in Costs, Study Shows
11/24/201516:21:51Statement of Changes in Beneficial Ownership (4)
11/24/201509:48:00U.S. Hot Stocks: Hot Stocks to Watch
11/24/201503:02:00Ackman's Pershing Buys More Of Valeant
11/23/201518:20:00Ackman's Pershing Square Boosts Stake in Valeant to 9.9%
11/23/201517:14:20Amended Statement of Beneficial Ownership (sc 13d/a)
11/23/201507:50:00Pfizer and Allergan Strike Huge Inversion Deal
11/22/201520:40:00Pfizer, Allergan Agree to Merge
11/22/201520:37:00Concerns Over Valeant Spread to Other Drug Makers
11/21/201513:00:033 Stocks Wall Street Hates
11/20/201517:43:47EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class...
11/20/201512:44:03Bill Ackman's Pershing Square Hedge Fund Is Hanging On to This...
11/20/201510:30:00VRX Investor Deadline Alert: Law Offices of Howard G. Smith Reminds...
11/20/201510:26:00/C O R R E C T I O N -- Valeant Pharmaceuticals International...
11/20/201510:26:00/C O R R E C T I O N -- Valeant Pharmaceuticals International...
11/20/201508:41:03How 1 Specialty-Drug Maker Hopes to Win Back Investor Trust
11/20/201508:39:03Should You Own Lone Pine Capital's 3 Favorite Stocks?
11/20/201508:00:00Valeant To Hold Investor Day On December 16
11/20/201508:00:00Valeant To Hold Investor Day On December 16

Valeant Pharma and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations